Acurion is an AI-driven biotech company that transforms frontline cancer care by using its OncoGaze™ platform to instantly predict clinically actionable genomic biomarkers from routine digital tissue biopsies. By delivering rapid genomic insights in seconds rather than months, it allows oncologists to bypass traditional wait times and quickly match cancer patients with optimal, life-saving precision therapies.